Home/Filings/4/0001209191-21-015520
4//SEC Filing

McClung David Mark 4

Accession 0001209191-21-015520

CIK 0001001233other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 9:10 PM ET

Size

8.5 KB

Accession

0001209191-21-015520

Insider Transaction Report

Form 4
Period: 2021-02-25
McClung David Mark
EVP Chief Business Officer
Transactions
  • Award

    Common Stock

    2021-02-25+40,000140,000 total
  • Award

    Stock Option (Right to Buy)

    2021-02-25+80,00080,000 total
    Exercise: $11.19Exp: 2031-02-24Common Stock (80,000 underlying)
Footnotes (3)
  • [F1]Represents 40,000 shares of common stock issuable upon settlement of restricted stock units ("RSUs"), granted to the Reporting Person on February 25, 2021 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP, as amended")) through such dates.
  • [F2]Includes 100,000 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on June 25, 2020. The RSUs will vest with respect to 1/3rd of the shares in three equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended through such dates.
  • [F3]One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of Continuous Service, as defined in the 2018 EIP, as amended, by the Reporting Person measured from the February 25, 2021 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through each such vesting date, and subject to acceleration as provided in the 2018 EIP, as amended.

Issuer

SANGAMO THERAPEUTICS, INC

CIK 0001001233

Entity typeother

Related Parties

1
  • filerCIK 0001811505

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 9:10 PM ET
Size
8.5 KB